October Pharma S.A.E (EGX:OCPH)

Market Cap	4.47B +223.6%
Revenue (ttm)	1.46B +22.5%
Net Income	165.09M +11.7%
EPS	13.76 +4.4%
Shares Out	12.00M
PE Ratio	27.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	388,756
Open	372.82
Previous Close	372.82
Day's Range	384.80 - 447.38
52-Week Range	111.00 - 447.38
Beta	0.73
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides human medicines in the form of capsules, tablets, suppositories, syrup, and drops for internal and sprays and inhalers for external use. October Pharma S.A.E was incorporated in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 15, 2026

Data Sources Report a data error